Moneycontrol PRO
HomeNewsIndiaCoronavirus pandemic | Manipur's first COVID-19 patient discharged from hospital

Coronavirus pandemic | Manipur's first COVID-19 patient discharged from hospital

Director of JNIMS Prof Thongam Bhimo said the woman was discharged as she had recovered completely from COVID-19 after successful treatment.

April 12, 2020 / 20:45 IST

The first COVID-19 positive patient of Manipur, who was undergoing treatment at Jawaharlal Nehru Institute of Medical Sciences (JNIMS), here was discharged from the hospital on Sunday, doctors said.

Director of JNIMS Prof Thongam Bhimo said the woman was discharged as she had recovered completely from COVID-19 after successful treatment.

The 23-year-old woman, a resident of Thangmeiband Lourung Purel Leikai area in Imphal West district, had returned from the UK.

After reaching Imphal she visited the Jawaharlal Nehru Institute of Medical Sciences (JNIMS) here on March 23, complaining of nasopharyngeal problems. Test reports of her swab and blood samples confirmed that she was infected with coronavirus.

She was admitted to the isolation ward of the JNIMS and was undergoing treatment.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Manipur Chief Minister N Biren Singh on April 9 said that the state government has decided to give Rs 35 lakh to the medical team and officials of JNIMS who treated the state's first COVID-19 patient.

Manipur so far has reported only one case of COVID-19.

Meanwhile, the 19 people of Moreh town in Tengnoupal district quarantined at the quarantine centre of RIMS have tested negative for COVID-19, said Prof Ahanthem Santa Singh, Director of Regional Institute of Medical Sciences (RIMS), Imphal on Sunday.

The RIMS director said that the 19 people were quarantined as they were close associates and relatives of a 66-year-old COVID-19 positive patient, who is undergoing treatment at a hospital in Bengaluru.

PTI
first published: Apr 12, 2020 08:45 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347